0001688087-16-000001.txt : 20161024 0001688087-16-000001.hdr.sgml : 20161024 20161024103500 ACCESSION NUMBER: 0001688087-16-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20161024 DATE AS OF CHANGE: 20161024 EFFECTIVENESS DATE: 20161024 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Gradient Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001688087 IRS NUMBER: 813796052 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-273059 FILM NUMBER: 161947495 BUSINESS ADDRESS: STREET 1: 2450 HOLCOMBE BLVD. STREET 2: TMCX SUITE 004 CITY: HOUSTON STATE: TX ZIP: 77021 BUSINESS PHONE: (713) 357-1024 MAIL ADDRESS: STREET 1: 2450 HOLCOMBE BLVD. STREET 2: TMCX SUITE 004 CITY: HOUSTON STATE: TX ZIP: 77021 D 1 primary_doc.xml X0707 D LIVE 0001688087 Gradient Pharmaceuticals, Inc. 2450 HOLCOMBE BLVD. TMCX SUITE 004 HOUSTON TX TEXAS 77021 (713) 357-1024 DELAWARE None None Corporation true 2016 Valentin Angelkov 2450 Holcombe Blvd. TMCx Suite 004 Houston TX TEXAS 77021 Executive Officer Director Martin Martinov 2450 Holcombe Blvd. TMCx Suite 004 Houston TX TEXAS 77021 Executive Officer Director Max Duckworth 2450 Holcombe Blvd. TMCx Suite 004 Houston TX TEXAS 77021 Director Biotechnology Decline to Disclose 06b false 2016-10-13 false true false 0 1500000 850000 650000 false 1 0 0 0 false Gradient Pharmaceuticals, Inc. /s/ Valentin Angelkov Valentin Angelkov Chief Executive Officer 2016-10-24